Disruption of Myeloid Cell Differentiation in Nonobese Diabetic Mice
Author Information
Author(s): B. Rumore-Maton, J. Elf, N. Belkin, B. Stutevoss, F. Seydel, E. Garrigan, S. A. Litherland
Primary Institution: University of Florida
Hypothesis
How does GM-CSF signaling affect STAT5 activation and myeloid cell differentiation in nonobese diabetic mice?
Conclusion
Excessive GM-CSF production in nonobese diabetic mice disrupts normal myeloid cell differentiation by interfering with STAT5 activation.
Supporting Evidence
- Defects in M-CSF signaling disrupt myeloid cell differentiation in NOD mice.
- NOD myeloid cells show excessive GM-CSF expression and persistent STAT5 activation.
- Blocking GM-CSF signaling can reduce STAT5 phosphorylation in NOD bone marrow cells.
- GM-CSF and M-CSF signaling interplay is crucial for normal myeloid differentiation.
Takeaway
In diabetic mice, a protein called GM-CSF is too high, which messes up how certain immune cells develop and work.
Methodology
The study used bone marrow cells from NOD and C57BL/6 mice, cultured them with GM-CSF and M-CSF, and analyzed STAT5 phosphorylation and myeloid differentiation through flow cytometry and deconvolution microscopy.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo environments.
Participant Demographics
Eight to twelve-week old female NOD and C57BL/6 mice were used.
Statistical Information
P-Value
p = .0240
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website